- Home
- Companies
- InMed Pharmaceuticals Inc.
- Products
- InMed Prodiol - Model CBC - ...
InMed Prodiol - Model CBC - Bioidentical Cannabinoids for your Health and Wellness Products
Our subsidiary, BayMedica, is a B2B supplier of highly pure, premium bioidentical rare cannabinoids as raw ingredients for health and wellness products. BayMedica has been able to reliably manufacture rare, minor cannabinoids that are bioidentical to those found in the plant. This means that our cannabinoids have an identical molecular structure to the cannabinoids found in the Cannabis plant. BayMedica has manufactured these rare cannabinoids at commercial scale as core ingredients in your health and wellness products. For health and wellness product manufacturers, our rare cannabinoid ingredients for B2B sale include tetrahydrocannabivarin (d9-THCV), cannabidivarin (CBDV), cannabichromene (CBC) and ultra-rare cannabinoid cannabicitran (CBT) available in any quantity needed.
Beyond THC and CBD, there are more than a hundred rare cannabinoids that have unique characteristics that may have different physiological effects. Research suggests that these rare, minor cannabinoids may have more beneficial effects than THC and CBD for certain applications. Until now, you couldn’t readily obtain these rare, minor cannabinoids because of their extremely low levels in the cannabis plant, making them impractical and expensive to extract and separate from unwanted components like THC. We have pioneered the application of pharmaceutical methods like chemical synthesis and biosynthesis to produce these valuable minor cannabinoids. Interested in learning more about the scientific research of rare cannabinoids?
Call us cannabinoid nerds. Our team of scientists at InMed and our subsidiary BayMedica have a depth of experience in cannabinoid biosynthesis, chemical synthesis and enzymatic biotransformation. We have been able to produce premium rare cannabinoids d9-THCV, CBDV, CBC and CBT at commercial scale.
While many scientists may be able to reproduce a cannabinoid in the lab, very few can take it to large scale production. We can and we have. We produce rare, minor cannabinoids with the consistent high quality and purity needed for the health and wellness industry. Our cannabinoids are made via “pharmaceutical-quality” techniques, are lab tested, and third-party certified. Our cannabinoids can be combined in precise ratios to produce Defined Spectrum™ formulations with putative synergistic, so-called, “entourage” or “potentiation” effects.
Our method is environmentally sustainable, free of pesticides, fertilizers, mold and heavy metals using pharmaceutical bioreactors. And each batch is third-party tested.